meglumine has been researched along with Lung Injury, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, GP; Li, L; Liu, Q; Wang, ZZ; Xiao, W; Xu, ZL; Yang, H; Zhou, J; Zong, SB | 1 |
| Fufaev, EE; Tulupov, AN | 1 |
2 other study(ies) available for meglumine and Lung Injury, Acute
| Article | Year |
|---|---|
Diterpene ginkgolides meglumine injection protects against paraquat-induced lung injury and pulmonary fibrosis in rats.
Topics: Acute Lung Injury; Animals; Antipyrine; Dose-Response Relationship, Drug; Edaravone; Ginkgolides; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Meglumine; Pulmonary Edema; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
[The detox and antioxidant activity of the reamberine in the complex treatment of the acute destructive lung disease].
Topics: Acute Lung Injury; Antioxidants; Humans; Lung Diseases; Meglumine; Succinates | 2012 |